Rocket Pharmaceuticals, Inc. (RCKT) Operating income 2016–2025
Rocket Pharmaceuticals, Inc. (RCKT) annual operating income history from SEC filings — each fiscal year as reported.
-$231.7MFY2025 · since FY2016: -$7.6M → -$231.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$231.7M | +15.2% |
| FY2024 | -$273.2M | -5.2% |
| FY2023 | -$259.7M | -15.7% |
| FY2022 | -$224.3M | -34.1% |
| FY2021 | -$167.2M | -24.5% |
| FY2020 | -$134.3M | -76.4% |
| FY2019 | -$76.2M | -7.0% |
| FY2018 | -$71.2M | -259.9% |
| FY2017 | -$19.8M | -161.1% |
| FY2016 | -$7.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice